1. Home
  2. USLM vs AKRO Comparison

USLM vs AKRO Comparison

Compare USLM & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

HOLD

Current Price

$121.24

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Logo Akero Therapeutics Inc.

AKRO

Akero Therapeutics Inc.

HOLD

Current Price

$54.53

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USLM
AKRO
Founded
1948
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
USLM
AKRO
Price
$121.24
$54.53
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$73.56
AVG Volume (30 Days)
57.0K
1.7M
Earning Date
10-29-2025
11-07-2025
Dividend Yield
0.20%
N/A
EPS Growth
32.23
N/A
EPS
4.55
N/A
Revenue
$364,849,000.00
N/A
Revenue This Year
$22.64
N/A
Revenue Next Year
$8.38
N/A
P/E Ratio
$26.69
N/A
Revenue Growth
20.27
N/A
52 Week Low
$80.47
$21.34
52 Week High
$154.79
$58.40

Technical Indicators

Market Signals
Indicator
USLM
AKRO
Relative Strength Index (RSI) 52.60 66.54
Support Level $116.76 $54.22
Resistance Level $122.10 $54.70
Average True Range (ATR) 3.33 0.14
MACD 0.50 -0.11
Stochastic Oscillator 65.33 64.18

Price Performance

Historical Comparison
USLM
AKRO

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: